Successful endonasal dacryocystorhinostomy in a patient with Wegener's granulomatosis
- PMID: 20054412
- PMCID: PMC2801633
- DOI: 10.2147/opth.s5920
Successful endonasal dacryocystorhinostomy in a patient with Wegener's granulomatosis
Abstract
Wegener's granulomatosis (WG) is one form of idiopathic autoimmune vasculitis. The disease has a predilection for the upper and lower respiratory tracts (lungs, nose, sinus), and kidneys. WG may be systemic, severe, and potentially lethal, but it may also be limited to the otolaryngological area or to the eyes and the orbits. Obstruction of the lacrimal pathway is a possible complication of the disease that affects approximately 7% of patients with WG. It usually occurs as a direct extension of sinonasal disease and typically is a late manifestation. Management of such a condition is generally viewed as difficult. We report the case of a patient with a quiescent WG limited to the otolaryngological area. This patient presented a bilateral obstruction of the nasolacrimal ducts caused by bilateral extensive adhesions in the nasal cavity. Because she had several episodes of left-side acute dacryocystitis which necessitated several courses of broad-spectrum antibiotics, she successfully underwent an endonasal endoscopic dacryocystorhinostomy using a diode laser and powered instrumentation. The authors describe the clinical case, the surgical technique, and review the literature.
Keywords: Wegener’s granulomatosis; diode; endonasal DCR; laser; powered instrumentation; recurrent dacryocystitis.
Figures


Similar articles
-
[Involvement of lacrimal organs in Wegener's granulomatosis].Vestn Oftalmol. 2009 Jul-Aug;125(4):33-6. Vestn Oftalmol. 2009. PMID: 19824446 Russian.
-
Recurrent bilateral dacryocystoceles in Wegener's granulomatosis: a rhinologic perspective.Am J Otolaryngol. 2006 Nov-Dec;27(6):409-12. doi: 10.1016/j.amjoto.2006.01.005. Am J Otolaryngol. 2006. PMID: 17084226
-
Exophthalmos as a presenting manifestation of limited Wegener's granulomatosis in a patient with prior graves' disease.Clin Med Case Rep. 2009 Jun 30;2:35-7. doi: 10.4137/ccrep.s731. eCollection 2009. Clin Med Case Rep. 2009. PMID: 24179371 Free PMC article.
-
Immune phenomena in localized and generalized Wegener's granulomatosis.Clin Exp Rheumatol. 2003 Nov-Dec;21(6 Suppl 32):S49-54. Clin Exp Rheumatol. 2003. PMID: 14740427 Review.
-
Clinic manifestations in granulomatosis with polyangiitis.Int J Immunopathol Pharmacol. 2016 Jun;29(2):151-9. doi: 10.1177/0394632015617063. Epub 2015 Dec 18. Int J Immunopathol Pharmacol. 2016. PMID: 26684637 Free PMC article. Review.
Cited by
-
Endoscopic vs. External Dacryocystorhinostomy in Granulomatosis with Polyangiitis: A Scoping Review of the Literature and Our Experience with Endoscopic Dacryocystorhinostomy.J Pers Med. 2025 Jul 1;15(7):278. doi: 10.3390/jpm15070278. J Pers Med. 2025. PMID: 40710395 Free PMC article. Review.
References
-
- White ES, Lynch JP. Pharmacological therapy for Wegener’s granulomatosis. Drugs. 2006;66(9):1209–1228. - PubMed
-
- Moosig F, Lamprecht P, Gross WL. Wegener’s granulomatosis: the current view. Clin Rev Allergy Immunol. 2008;35(1–2):19–21. - PubMed
-
- Erickson VR, Hwang PH. Wegener’s granulomatosis: current trends in diagnosis and management. Curr Opin Otolaryngol Head Neck Surg. 2007 Jun;15(3):170–176. - PubMed
-
- Khan AM, Elahi F, Hashmi SR, et al. Wegener’s granulomatosis: a rare, chronic and multisystem disease. Surgeon. 2006;4(1):45–52. - PubMed
-
- Stone JH.Wegener’s Granulomatosis Etanercept Trial Research group. Limited versus severe Wegener’s granulomatosis: baseline data on patients in the Wegener’s granulomatosis etanercept trial Arthritis Rheum 2004501334–335.; author reply, 335–336. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Molecular Biology Databases